Latest Insider Transactions at New Amsterdam Pharma CO N.V. (NAMS)
This section provides a real-time view of insider transactions for New Amsterdam Pharma CO N.V. (NAMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NewAmsterdam Pharma Co N.V. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NewAmsterdam Pharma Co N.V.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
201,673
+50.0%
|
-
|
|
Feb 13
2024
|
Louis G Lange |
BUY
Open market or private purchase
|
Indirect |
5,000
+16.73%
|
$95,000
$19.0 P/Share
|